Login
Home
Charts
Search
Watchlist
Products

Stallion India Fluorochemicals Ltd

STALLION·NSE
226.23-2.28%Tue, 22 Sept '26 15:50

Stallion India Fluorochemicals Ltd

STALLION
NSE
226.23
-2.28%
|Tue, 22 Sept '26 15:50
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,624Cr
Close
Close Price
226.00
Industry
Industry
Industrial Gas
PE
Price To Earnings
42.32
PS
Price To Sales
5.94
Revenue
Revenue
442Cr
Rev Gr TTM
Revenue Growth TTM
6.49%
PAT Gr TTM
PAT Growth TTM
51.93%

Quarterly Results

Standalone
Numbers
Percentage
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
736885152110106105110121
Growth YoY
Revenue Growth YoY%
51.056.322.9-27.49.9
Expenses
ExpensesCr
6166711339690939499
Operating Profit
Operating ProfitCr
12214191416121622
OPM
OPM%
16.92.916.812.412.914.811.214.918.1
Other Income
Other IncomeCr
000200213
Interest Expense
Interest ExpenseCr
122200000
Depreciation
DepreciationCr
000000010
PBT
PBTCr
11112181415131725
Tax
TaxCr
303544266
PAT
PATCr
8110131011111119
Growth YoY
PAT Growth YoY%
23.01,243.513.8-17.679.3
NPM
NPM%
11.51.311.58.89.410.810.69.915.3
EPS
EPS
1.40.11.61.51.11.21.21.31.6
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
736885152110106105110121
Growth YoY
Revenue Growth YoY%
51.056.322.9-27.49.9
Expenses
ExpensesCr
6166711339690939499
Operating Profit
Operating ProfitCr
12214191416121622
OPM
OPM%
16.92.916.812.412.914.811.214.918.1
Other Income
Other IncomeCr
000200213
Interest Expense
Interest ExpenseCr
122200000
Depreciation
DepreciationCr
000000010
PBT
PBTCr
11112181415131725
Tax
TaxCr
303544266
PAT
PATCr
8110131011111119
Growth YoY
PAT Growth YoY%
23.01,243.513.8-17.679.3
NPM
NPM%
11.51.311.58.89.410.810.69.915.3
EPS
EPS
1.40.11.61.51.11.21.21.31.6

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
118186226233377431442
Growth
Revenue Growth%
57.621.33.461.814.16.5
Expenses
ExpensesCr
104153210209330373376
Operating Profit
Operating ProfitCr
14331524485866
OPM
OPM%
11.717.56.710.212.613.414.9
Other Income
Other IncomeCr
101327
Interest Expense
Interest ExpenseCr
0114611
Depreciation
DepreciationCr
1221112
PBT
PBTCr
13301322425970
Tax
TaxCr
4936101518
PAT
PATCr
10211015324452
Growth
PAT Growth%
114.4-53.858.7108.935.651.9
NPM
NPM%
8.311.44.36.68.610.211.8
EPS
EPS
1.83.81.82.64.25.35.3
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
118186226233377431442
Growth
Revenue Growth%
57.621.33.461.814.16.5
Expenses
ExpensesCr
104153210209330373376
Operating Profit
Operating ProfitCr
14331524485866
OPM
OPM%
11.717.56.710.212.613.414.9
Other Income
Other IncomeCr
101327
Interest Expense
Interest ExpenseCr
0114611
Depreciation
DepreciationCr
1221112
PBT
PBTCr
13301322425970
Tax
TaxCr
4936101518
PAT
PATCr
10211015324452
Growth
PAT Growth%
114.4-53.858.7108.935.651.9
NPM
NPM%
8.311.44.36.68.610.211.8
EPS
EPS
1.83.81.82.64.25.35.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212556179116
Reserves
ReservesCr
28491664222565
Current Liabilities
Current LiabilitiesCr
1133655743256
Non Current Liabilities
Non Current LiabilitiesCr
110001
Total Liabilities
Total LiabilitiesCr
15398126200334737
Current Assets
Current AssetsCr
13480109186307660
Non Current Assets
Non Current AssetsCr
191817142777
Total Assets
Total AssetsCr
15398126200334737
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212556179116
Reserves
ReservesCr
28491664222565
Current Liabilities
Current LiabilitiesCr
1133655743256
Non Current Liabilities
Non Current LiabilitiesCr
110001
Total Liabilities
Total LiabilitiesCr
15398126200334737
Current Assets
Current AssetsCr
13480109186307660
Non Current Assets
Non Current AssetsCr
191817142777
Total Assets
Total AssetsCr
15398126200334737

Cash Flow

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-88-3-73-1339
Investing Cash Flow
Investing Cash FlowCr
-2-1-1312-20-253
Financing Cash Flow
Financing Cash FlowCr
12-8167676367
Net Cash Flow
Net Cash FlowCr
2-1-11543154
Free Cash Flow
Free Cash FlowCr
-107-3-75-18-10
CFO To PAT
CFO To PAT%
-85.237.9-28.8-474.6-41.589.8
CFO To EBITDA
CFO To EBITDA%
-60.724.5-18.7-307.8-28.168.0
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-88-3-73-1339
Investing Cash Flow
Investing Cash FlowCr
-2-1-1312-20-253
Financing Cash Flow
Financing Cash FlowCr
12-8167676367
Net Cash Flow
Net Cash FlowCr
2-1-11543154
Free Cash Flow
Free Cash FlowCr
-107-3-75-18-10
CFO To PAT
CFO To PAT%
-85.237.9-28.8-474.6-41.589.8
CFO To EBITDA
CFO To EBITDA%
-60.724.5-18.7-307.8-28.168.0

Ratios

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5371,1892,624
Price To Earnings
Price To Earnings
16.627.142.3
Price To Sales
Price To Sales
1.42.85.9
Price To Book
Price To Book
1.81.83.9
EV To EBITDA
EV To EBITDA
9.713.632.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
21.224.615.319.323.6
OPM
OPM%
11.717.56.710.212.613.414.9
NPM
NPM%
8.311.44.36.68.610.211.8
ROCE
ROCE%
28.049.515.813.516.08.48.4
ROE
ROE%
24.734.613.812.310.86.46.4
ROA
ROA%
6.421.57.77.79.76.06.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5371,1892,624
Price To Earnings
Price To Earnings
16.627.142.3
Price To Sales
Price To Sales
1.42.85.9
Price To Book
Price To Book
1.81.83.9
EV To EBITDA
EV To EBITDA
9.713.632.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
21.224.615.319.323.6
OPM
OPM%
11.717.56.710.212.613.414.9
NPM
NPM%
8.311.44.36.68.610.211.8
ROCE
ROCE%
28.049.515.813.516.08.48.4
ROE
ROE%
24.734.613.812.310.86.46.4
ROA
ROA%
6.421.57.77.79.76.06.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Stallion India Fluorochemicals is a specialist that sits between the world’s giant gas producers and the air conditioner in your home or the factory making your phone - it imports refrigerant and industrial gases in bulk, precisely blends and purifies them, and then delivers them in ready-to-use cylinders to over 200 customers across more than 15 industries. The business began in 1992 when India’s first standalone HFC debulking and bottling facility was set up at Panvel near Mumbai, and it has spent three decades evolving from a focused distributor into an integrated processor and blender that now handles more than 40 different gases. The recurring approach that explains everything else is a forward-integrated, decentralized network of facilities that cuts out the long-distance transport costs its larger, factory-based competitors must bear - a model built on moving gas in 20,000-litre bulk tanks to multiple blending sites, so it can deliver faster and cheaper than rivals who ship from a single manufacturing location. # Business segments A single engine today - refrigerant and industrial gas processing, blending and distribution - with three expansion bets under construction that will add liquid helium and semiconductor gases, backward integration into manufacturing, and a new South Indian facility, all built on the same decentralized supply-chain logic. ## 1. Refrigerant and industrial gas processing: the aftermarket engine that pays for everything else **The company earns its living by importing bulk refrigerant gases, blending them into custom formulations, and delivering them to the replacement and repair market - a segment that delivers substantially higher margins than selling to equipment manufacturers on fixed annual contracts.** - **Bulk logistics that slash costs** - by moving cargo in 20,000-litre bulk tanks between its own facilities, the company keeps transport, logistics and manpower costs to almost one-third of what backward-integrated rivals spend, and its sites operate below unionized manpower strength while competitors carry 300 to 400 people at a single unionized plant. - **The aftermarket is the profit pool** - roughly 80% of India’s domestic HVAC-R demand comes from replacement, repair and maintenance, and this aftermarket business carries higher margins and greater price mobility than OEM contracts, where prices are fixed annually and cost increases are hard to pass on. For newer products like HFOs, the mix starts at 100% OEM and gradually inverts over 12 years until the aftermarket accounts for 80% of sales. - **Sticky customers, once qualified** - the customer qualification process takes two to three years, and once a customer is onboarded they do not easily switch for a cheaper alternative, which creates a durable revenue base across industries as varied as automobiles, electronics, fire-fighting, pharmaceuticals, semiconductors and defence. - **Sourced from China, blended in India** - the basic raw material is fluorspar, and the biggest global supplier is China, followed by Mexico and Vietnam; the company buys from third-party suppliers at prevailing market prices and generally does not lock into long-term supply arrangements, which gives it flexibility but also exposes it to import price swings. ## 2. Liquid helium and semiconductor gases: the high-purity bet under construction **The company is building a liquid helium and specialty gas capability at its Khalapur facility, targeting demand from semiconductor fabrication, solar cell manufacturing and space applications - with a planned capacity of 1,200 metric tonnes per annum and completion expected by mid-2026.** - **Helium from Qatar, technology from Portugal** - a long-term sourcing partnership with Sharjah Oxygen Company secures liquid helium from RAS Gases and Oilfields in Qatar, one of the world’s key helium supply hubs, while a technology tie-up with Portugal’s SYS ADVANCE brings containerised helium recovery and liquefaction systems qualified by European Space Agencies for space and cryogenic applications. - **ISRO as an anchor customer in the making** - the company is actively working with the Indian Space Research Organisation on long-term helium recovery and liquefaction support for recycling helium used in space programmes, and has already participated in a large tender floated by ISRO. - **Same facility, new capability** - the semiconductor and specialty gas debulking and blending unit is being added at the existing Khalapur site, which already serves as the company’s hub for refrigerant blenders and specialty gases, so the expansion leverages existing infrastructure rather than starting from scratch. ## 3. Backward integration into refrigerant manufacturing: from blender to molecule-maker **A 10,000 metric-tonne-per-annum R-32 manufacturing plant is under construction at Bhilwara, Rajasthan, with commissioning targeted by August 2026, and a follow-on HFO manufacturing plant is planned on adjacent land - marking a shift from pure processing into making the gas itself.** - **R-32 first, HFO next** - the Bhilwara R-32 facility has received environmental clearance valid for ten years and will also produce hydrochloric acid as a by-product and blended refrigerants including R-410A and R-407C with aggregate blending capacity of 7,500 metric tonnes per annum. A second plant for HFOs - next-generation refrigerants with minimal environmental impact - has been agreed with the Rajasthan government, with construction to start in 2027 on land already acquired. - **Promoter-funded, not equity-diluted** - the promoter sold a portion of his shareholding in November 2025 and infused the resulting ₹45.74 crores into the company on an interest-free basis without any equity dilution, specifically to fund the R-32 facility’s development. ## 4. Mambattu facility: the South Indian bridgehead **A new blending and debulking plant at Mambattu, Andhra Pradesh, will replicate the company’s decentralized model in South India, adding 7,200 metric tonnes per annum of HFO and HFC blending capacity alongside helium and semiconductor gas handling.** - **Copying the playbook southwards** - the Mambattu facility will handle refrigerant debulking, blending and storage of HFCs, HFOs and their blends, plus hydrocarbon storage and a helium and semiconductor gases unit similar to the one at Khalapur, all targeted for completion by mid-2026. - **Filling the map** - with Mambattu, the company’s operational footprint will cover roughly 88,000 square metres across India, and it has stated plans to expand further into Eastern India, completing a pan-Indian network that already serves the North, West and South. # Group structure and partners **The company is a standalone entity with no subsidiaries, led by its founder and built on decades-long relationships with global gas majors who use Stallion as their route into the Indian aftermarket.** - The company has no subsidiary or associate companies; Stallion Enterprise, previously owned by the founder Mr. Shazad Sheriar Rustomji, was consolidated into the company through a slump sale in September 2023, creating a single integrated entity. - A 2002 joint marketing and distribution agreement with Honeywell for HFCs and fluorines, a 2013 sourcing and logistics partnership with Daikin Japan for HFC-32, and a 2017 agreement with Honeywell to introduce Solstice HFO refrigerants in India form the backbone of the company’s global supply relationships. - The Rajasthan government, through RIICO, is facilitating land allotment, permissions and clearances for both the R-32 and HFO manufacturing plants under signed MoUs.

Documents — Stallion India Fluorochemicals Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/vktibuidh1bvny9ghyap5ua9.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/w57nqj8lvr8e4dk01zg54r3g.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/x98mfsa7gwkdvdg8v6ys4rqd.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/dzipt969kvtm42f3wz6ghn4s.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/7ju5fls45m0ye5xxcxa7dklg.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/d0p51xzwhsdbqdj2mjemks20.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/x74rbytow42j412c2e5dqnt4.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/8zj265x8wtmcizg8tfpbrfu9.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/78h88t4zr7lxxajfn63p9zdo.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/mea0fbplbmmx47qz02ioktuw.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/rjleqio8h9lgvrdu1774w7cp.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/vci456gwhr23l5gu8wrmblqu.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/l64sw786vfzk183ssvxizeuk.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/3c890wkw24g49zfpe1z1aggx.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/yvwearzwyawmdy0drgxtei5u.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/q0tf5gws97kwp8m17bfaanu7.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/7brv48kxmfu6t88fcti93zpb.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/h5ldfx6m0o80l40zubti07j5.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/5rtrrho1j50uwanpei1l9h95.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/a8mq871rn3i1u81h9qrcgodj.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/s94m411ci8v9b6c46vbtfs2z.pdf

Concall Transcript Summaries — Stallion India Fluorochemicals Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ASTALLION/transcript-notes/202606/vktibuidh1bvny9ghyap5ua9.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ASTALLION/transcript-notes/202603/w57nqj8lvr8e4dk01zg54r3g.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ASTALLION/transcript-notes/202512/x98mfsa7gwkdvdg8v6ys4rqd.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ASTALLION/transcript-notes/202509/dzipt969kvtm42f3wz6ghn4s.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ASTALLION/transcript-notes/202506/7ju5fls45m0ye5xxcxa7dklg.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ASTALLION/transcript-notes/202503/d0p51xzwhsdbqdj2mjemks20.pdf